click below
click below
Normal Size Small Size show me how
Therapeutic antibodi
FA Immuno
Question | Answer |
---|---|
CD52 | Alemtuzumab |
CLL | Alemtuzumab |
colorectal Ca, RCC | Bavacizumab |
Stage IV colorectal Ca, head and neck Ca | Cetuximab |
B cell non-Hodgkin lymphoma, CLL, RA, ITP | Rituximab |
Breast Ca | Trastuzumab |
VEGF | Ranibizumab, bevacizumab |
EGFR | Cetuximab |
CD20 | Rituximab |
Her2/neu | Trastuzumab |
Soluble TNF alpha | Adalimumab, infliximab |
IBD, RA, Ankylosing spondylitis, psoriasis | Adalimumab, infliximab |
decoy TNF alpha receptor | Etanercept |
Complement protein C5 | Eculizumab |
PNH | Eculizumab |
alpha 4 integrin | Natalizumab |
MS, Crohn disease | Natalizumab |
Platelet glycoprotein IIb/IIIa | Abciximab |
antiplatelet agent for prevention of ischemic complications in patients undergoing percutaneous coronary intervention | Abciximab |
RANKL | Denosumab |
osteoporosis | Denosumab |
inhibits osteoclast maturation (mimics osteoprotegerin) | Denosumab |
Antidote for digoxin toxicity | Digoxin immune Fab |
IgE | Omalizumab |
Allergic asthma, prevents IgE binding to FcERI | Omalizumab |
RSV F Protein | Palivizumab |
RSV prophylaxis for high risk infants | Palivizumab |
neovascular age related macular degeneration | Ranibizumab, bevacizumab |